Q3week Carboplatin With Weekly Abraxane And Avastin + Subsequent Dose-Dense Ac With Avastin As Neoadjuvant Therapy In Resectable And Unresectable (Stage Iia-Iiib) Her2-Negative Breast Cancer
Phase of Trial: Phase II
Latest Information Update: 15 Feb 2018
At a glance
- Drugs Bevacizumab (Primary) ; Cyclophosphamide (Primary) ; Paclitaxel (Primary) ; Carboplatin; Doxorubicin
- Indications Breast cancer
- Focus Therapeutic Use
- 02 Jun 2017 Results assessing mitochondrial gene fusions in breast cancer by RNA sequencing of pre and post treatment breast cancer samples obtained from neoadjuvant clinical trials BrUOG 211A/211B, presented at the 53rd Annual Meeting of the American Society of Clinical Oncology.
- 22 Apr 2013 Planned end date changed from 1 Jun 2013 to 1 Dec 2016 as reported by ClinicalTrials.gov.
- 01 Feb 2012 Planned End Date changed from 1 Jun 2012 to 1 Jun 2013 as reported by ClinicalTrials.gov.